ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ASMB vs RZLT // RSI-14 & 200D SMA MOMENTUM

Assembly Biosciences Inc. (NASDAQ) VS. Rezolute Inc. (NV) (NASDAQ) • 15-METRIC TALLY: ASMB 4 — RZLT 1
▲ RSI-14 & 200D SMA MOMENTUM LEADER: RZLT
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ASMB VS. RZLT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ASMB RZLT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -6.50% -35.00% +28.50 ASMB /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -9.69% -17.33% +7.64 ASMB /fcf-yield <GO>
Operating Margin -16.80% — — TIE /operating-margins <GO>
Net Profit Margin -8.50% — — TIE /net-margins <GO>
Revenue Growth (YoY) 153.50% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 1.57 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 2/9 +1.00 ASMB /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 41.8 50.6 -8.80 RZLT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $424.7M $398.5M $26.2M ASMB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ASMB REV RZLT REV ASMB GROSS % RZLT GROSS % ASMB FCF RZLT FCF
FY 2025 $72.3M $0 — — -$41.2M -$69.1M
FY 2024 $28.5M $0 — — -$51.1M -$57.4M
FY 2023 $0 $0 — — $22.7M -$44.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ASMB // BETA —
RZLT // BETA —